Sagimet Biosciences Inc. Series A Common Stock (SGMT : NASDAQ)
Common Stock
$10.46
USD
+0.00 (%)
Last updated: 2026-09-17
Get SGMT alerts:
SGMT
Sagimet Biosciences Inc. Series A Common Stock
WealthAwesomePerformance
1 Day
+0.00%
1 Week
-3.68%
1 Month
+0.29%
YTD
+60.18%
Key Statistics
Market Cap
$650.18M
52W High
$11.45
52W Low
$4.50
P/E Ratio
-
50 Day MA
$9.06
200 Day MA
$6.94
Beta
3.49
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 9/17/2026 | $10.69 | $11.34 | $10.68 | $11.17 | $11.17 | 1,019,048 |
| 9/16/2026 | $10.51 | $10.62 | $10.25 | $10.46 | $10.46 | 620,552 |
| 9/15/2026 | $10.80 | $10.84 | $10.31 | $10.46 | $10.46 | 852,734 |
| 9/14/2026 | $10.96 | $11.10 | $10.82 | $10.88 | $10.88 | 516,759 |
| 9/11/2026 | $11.33 | $11.35 | $10.77 | $10.88 | $10.88 | 639,392 |
| 9/10/2026 | $10.75 | $11.45 | $10.67 | $11.06 | $11.06 | 937,700 |
| 9/9/2026 | $11.25 | $11.27 | $10.69 | $10.86 | $10.86 | 1,249,900 |
| 9/8/2026 | $10.84 | $11.17 | $10.65 | $10.71 | $10.71 | 805,400 |
| 9/4/2026 | $10.79 | $10.98 | $10.53 | $10.94 | $10.94 | 1,250,100 |
| 9/3/2026 | $11.21 | $11.24 | $10.62 | $10.92 | $10.92 | 1,142,100 |
Analyst Price Targets
Based on 7 analysts covering SGMT · as of Sep 17, 2026
Wall Street analysts forecast SGMT stock price to rise 183.0% over the next 12 months.
Consensus
Strong Buy4.71 / 5.00
Avg. Target
US$29.60
+183.0% Upside
Current Price
US$10.46
Last close
Analyst Breakdown (7 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on SGMT's historical volatility
30-Day Vol
55.1%
Annualized
90-Day Vol
62.1%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
US$13.35
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$11.86 | US$9.80 – US$14.34 |
| 60 trading days | US$12.58 | US$9.62 – US$16.46 |
| 90 trading days | US$13.35 | US$9.61 – US$18.56 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Sagimet Biosciences Inc. Series A Common Stock
Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops novel therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional metabolic and fibrotic pathways in the United States. The company's lead drug candidate is Denifanstat, an oral, once-daily pill and selective FASN inhibitor for the treatment of metabolic dysfunction-associated steatohepatitis, acne, and select forms of cancer. It also develops TVB-3567, a FASN inhibitor for the treatment of acne indication; and other oncology programs, such as solid tumor and glioblastoma. The company was formerly known as 3-V Biosciences, Inc. and changed its name to Sagimet Biosciences Inc. in August 2019. Sagimet Biosciences Inc. was incorporated in 2006 and is headquartered in San Mateo, California.
Financials
- Revenue (TTM)
- $0
- EBITDA
- -
- Profit Margin
- 0.00%
- ROE (TTM)
- -24.37%
- EPS (Diluted)
- -1.26
- Book Value
- 4.15
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About SGMT.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| DLXY | Delixy Holdings Limited Ordinary Shares | $2.29 | +451.81% |
| MEDS | DataMEDS AI, Inc. | $6.07 | +274.69% |
| SNYR | Synergy CHC Corp. Common Stock | $0.27 | +234.15% |
| QCLS | Q/C Technologies, Inc. | $0.96 | +118.45% |
| AEHL | Antelope Enterprise Holdings Ltd | $9.22 | +78.68% |
| ZTG | Zenta Group Company Limited | $1.18 | +75.33% |
| PDSB | PDS Biotechnology Corp | $0.99 | +69.25% |
| TPST | Tempest Therapeutics Inc | $1.21 | +60.18% |